ESTA - エスタブリッシュメント・ラボズ・ホ―ルディングス (Establishment Labs Holdings Inc.)

ESTAのニュース

   Establishment Labs: More Constructive, But Not At 10x Sales  2023/03/03 17:44:08 Seeking Alpha
Establishment Labs'' top-line growth was commendable with upsides in key markets, especially Brazil. Click here to read my most recent analysis of ESTA.
   ROSEN, A LEADING LAW FIRM, Encourages Establishment Labs Holdings Inc. Investors with Losses to Inquire About Securities Class Action Investigation - ESTA  2023/03/01 20:14:00 PR Newswire
NEW YORK, March 1, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Establishment Labs Holdings Inc. (NASDAQ: ESTA) resulting from allegations that the Company may have…
   Establishment Labs GAAP EPS of -$0.55 beats by $0.13, revenue of $43.81M beats by $0.73M  2023/02/27 21:03:58 Seeking Alpha
Establishment Labs press release (ESTA): Q4 GAAP EPS of -$0.55 beats by $0.13.Revenue of $43.81M (+24.1% Y/Y) beats by $0.73M.Fourth and final module submitted to U.S. FDA for…
   Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results  2023/02/27 21:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has submitted the fourth and final module of its modular submission to the FDA for premarket approval of Motiva Implants® in the United States. The company also provided unaudited financial results for the fourth quarter and full year ended December 31, 2022
   Establishment Labs Hldgs Earnings Preview  2023/02/24 18:02:13 Benzinga
Establishment Labs Hldgs (NASDAQ: ESTA ) is set to give its latest quarterly earnings report on Monday, 2023-02-27. Here''s what investors need to know before the announcement. Analysts estimate that Establishment Labs Hldgs will report an earnings per share (EPS) of $-0.68. Establishment Labs Hldgs bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, … Full story available on Benzinga.com
   Establishment Labs: More Constructive, But Not At 10x Sales  2023/03/03 17:44:08 Seeking Alpha
Establishment Labs'' top-line growth was commendable with upsides in key markets, especially Brazil. Click here to read my most recent analysis of ESTA.
   ROSEN, A LEADING LAW FIRM, Encourages Establishment Labs Holdings Inc. Investors with Losses to Inquire About Securities Class Action Investigation - ESTA  2023/03/01 20:14:00 PR Newswire
NEW YORK, March 1, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Establishment Labs Holdings Inc. (NASDAQ: ESTA) resulting from allegations that the Company may have…
   Establishment Labs GAAP EPS of -$0.55 beats by $0.13, revenue of $43.81M beats by $0.73M  2023/02/27 21:03:58 Seeking Alpha
Establishment Labs press release (ESTA): Q4 GAAP EPS of -$0.55 beats by $0.13.Revenue of $43.81M (+24.1% Y/Y) beats by $0.73M.Fourth and final module submitted to U.S. FDA for…
   Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results  2023/02/27 21:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has submitted the fourth and final module of its modular submission to the FDA for premarket approval of Motiva Implants® in the United States. The company also provided unaudited financial results for the fourth quarter and full year ended December 31, 2022
   Establishment Labs Hldgs Earnings Preview  2023/02/24 18:02:13 Benzinga
Establishment Labs Hldgs (NASDAQ: ESTA ) is set to give its latest quarterly earnings report on Monday, 2023-02-27. Here''s what investors need to know before the announcement. Analysts estimate that Establishment Labs Hldgs will report an earnings per share (EPS) of $-0.68. Establishment Labs Hldgs bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, … Full story available on Benzinga.com
   Establishment Labs to Present at the Jefferies Healthcare Conference  2022/06/06 12:00:00 Business Wire
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 10:30 am Eastern Time. A live webcast of the presentation will
   Establishment Labs GAAP EPS of -$0.24 beats by $0.13, revenue of $38.45M beats by $3.19M  2022/05/09 20:23:37 Seeking Alpha
Establishment Labs press release (ESTA): Q1 GAAP EPS of -$0.24 beats by $0.13.Revenue of $38.45M (+26.9% Y/Y) beats by $3.19M.2022 revenue guidance of $155 million to $165 million vs
   Establishment Labs Reports Record First Quarter 2022 Financial Results  2022/05/09 20:00:00 Wallstreet:Online
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the first quarter ended March 31, 2022. First Quarter Highlights and Outlook Strong momentum with first quarter worldwide sales of $38.5 million, an increase
   Establishment Labs to Announce First Quarter 2022 Financial Results on May 9  2022/04/28 12:00:00 Business Wire
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2022 after the market closes on Monday, May 9, 2022, and will host a conference call at 4:30 pm ET that day to discuss those results. To participate in the conference call, dial (877) 407-8037 (U.S
   Establishment Labs signs $225M credit facility with Oaktree  2022/04/26 12:48:21 Seeking Alpha
Establishment Labs (ESTA) entered into a $225M term loan financing facility with funds managed by Oaktree Capital which could fund its business to cash flow positive.The facility…

calendar